Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
Hypertension ; 81(3): 415-425, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37823260

ABSTRACT

Excessive salt intake raises blood pressure, but the implications of this observation for human health have remained contentious. It has also been recognized for many years that potassium intake may mitigate the effects of salt intake on blood pressure and possibly on outcomes such as stroke. Recent large randomized intervention trials have provided strong support for the benefits of replacing salt (NaCl) with salt substitute (75% NaCl, 25% KCl) on hard outcomes, including stroke. During the same period of time, major advances have been made in understanding how the body senses and tastes salt, and how these sensations drive intake. Additionally, new insights into the complex interactions between systems that control sodium and potassium excretion by the kidneys, and the brain have highlighted the existence of a potassium switch in the kidney distal nephron. This switch seems to contribute importantly to the blood pressure-lowering effects of potassium intake. In recognition of these evolving data, the United States Food and Drug Administration is moving to permit potassium-containing salt substitutes in food manufacturing. Given that previous attempts to reduce salt consumption have not been successful, this new approach has a chance of improving health and ending the 'Salt Wars'.


Subject(s)
Hypertension , Sodium, Dietary , Stroke , Humans , Sodium, Dietary/pharmacology , Sodium Chloride, Dietary/adverse effects , Hypertension/etiology , Hypertension/prevention & control , Sodium Chloride , Blood Pressure/physiology , Potassium , Potassium, Dietary/pharmacology
2.
Anaesthesiologie ; 72(10): 757-770, 2023 Oct.
Article in German | MEDLINE | ID: mdl-37768358

ABSTRACT

The paired kidneys play a significant role in the human body due to the multitude of physiological tasks. Complex biochemical processes keep the sensitive electrolyte and water balance stable and thus ensure the organism's ability to adapt to exogenous and endogenous factors, which is essential for survival. The drug class of diuretics includes substances with very differing pharmacological characteristics. The functioning of the nephron is therefore indispensable for a deeper understanding of the pharmacodynamics, pharmacokinetics and side effect profile of diuretics. In the treatment of acute heart failure with pulmonary congestion, certain diuretics represent an important therapeutic option to counteract hypervolemia and thus an increase in preload. According to current data, diuretics have no proven benefits in the treatment or prevention of acute kidney injury but they can counteract hypervolemia and under certain conditions even reduce the use of renal replacement procedures.

3.
Hypertension ; 80(9): 1860-1870, 2023 09.
Article in English | MEDLINE | ID: mdl-37377014

ABSTRACT

BACKGROUND: The expression of NGAL/lcn2 (neutrophil gelatinase-associated lipocalin) is directly modulated by mineralocorticoid receptor activation but its role in blood pressure control is unclear. METHODS: a potential relationship between NGAL plasma levels, systolic blood pressure and urinary Na excretion was assessed in the STANISLAS cohort. The specific role of NGAL/lcn2 in salt-sensitive hypertension was studied using lcn2-knockout mice (lcn2 KO) fed with low-Na diet (0Na). RESULTS: we show that NGAL plasma levels positively correlate with systolic blood pressure, whereas they negatively correlate with urinary Na excretion in subjects of the STANISLAS cohort. Prolonged feeding of lcn2 KO mice with a 0Na diet induced lower systolic blood pressure than that of the control group (wildtype), suggesting a role for NGAL/lcn2 in Na-balance homeostasis. Short-term or prolonged 0Na increased Na-Cl cotransporter (NCC) phosphorylation in the cortex of wildtype mice, which was prevented in lcn2 KO mice. Recombinant mouse lcn2 injections in lcn2 KO mice induced NCC phosphorylation in the kidney cortex, associated with decreased urinary Na excretion. Ex vivo experiments using kidney slices from lcn2 KO mice showed increased NCC phosphorylation by recombinant murine lcn2. In addition, recombinant murine lcn2 induced activation of CamK2ß (calcium/calmodulin-dependent protein kinase II ß subunit) phosphorylation in lcn2 KO mice and in kidney slices, providing an underlying mechanism involved in lcn2-induced NCC phosphorylation. Indeed, the inhibition of CamK2ß prevented NCC phosphorylation induced by recombinant lcn2 in kidney slices. CONCLUSIONS: we highlight a novel role of NGAL/lcn2 as a modulator of the activity of the renal sodium transporter NCC affecting salt-sensitive blood pressure.


Subject(s)
Aldosterone , Hypertension , Mice , Animals , Solute Carrier Family 12, Member 3/metabolism , Lipocalin-2/genetics , Lipocalin-2/metabolism , Kidney/metabolism , Sodium/metabolism , Mice, Knockout
4.
J Pak Med Assoc ; 73(Suppl 1)(2): S69-S74, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36788394

ABSTRACT

Stem cell research is rapidly expanding and has provided novel concepts in understanding and managing various diseases. Recent progress in translational and experimental urology has given insight about their utilization in the treatment and regeneration of urological structures. Chronic degenerative and neurological conditions affecting the lower urinary tract (LUT) are excellent targets for stem cell therapy. Their role has been particularly studied in bladder dysfunction, painful bladder syndrome, bladder outflow obstruction, stress urinary incontinence, erectile dysfunction, and urethral regeneration. However, the translation of this research in clinical domain is slow. Furthermore, regeneration of kidney using stem cells has been explored but remains challenging due to complexities of nephrons. Stem cells research in uro-oncology, especially bladder and prostate cancer, provided significant insight in understanding of pathogenesis processes and expanded potential therapeutic options. This review is centered to discuss application of stem cells and regenerative medicine in urology particularly human subject clinical studies and trials published in recent years.


Subject(s)
Urinary Incontinence, Stress , Urology , Male , Humans , Urinary Bladder , Regenerative Medicine , Stem Cells
5.
Gac. méd. boliv ; 46(1)2023.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1448294

ABSTRACT

La nefrectomia parcial ha proporcionado múltiples beneficios principalmente en pacientes con lesiones renales de pequeño tamaño o con enfermedades que puedan afectar el funcionamiento renal a largo plazo, también en pacientes con riñón único funcional, ya sea congènita o por cirugía, enfermedad renal terminal, tumores renales bilaterales o con enfermedades cromosómicas que afecten la función renal.Se presenta el caso de un paciente de 52 años con un tumor de riñón derecho de 10 cm de diámetro en región interpolar, con riñón izquierdo sin función, por proceso obstructivo de estenosis ureteropielica congènita. Se realizó nefrectomia parcial derecha a pesar de la localización y tamaño del tumor renal, obteniendo excelentes resultados oncológicos y funcionales. Con un seguimiento a doce meses de evaluación post-operatoria sin datos de actividad tumoral, presentando una función renal con creatinina 1.6 mg/dl, con evolución satisfactoria. Conclusiones: La nefrectomia parcial es el manejo ideal para tumores renales pequeños que están localizados en la corteza renal y en los extremos polares del riñón o con un riñón contralateral sin función; pero hay el dilema cuando se presentan en pacientes con función renal baja o tumores localizados cerca del hilio renal de más de 5 cm de diámetro, se debe tomar los riesgo de intentar realizar este procedimiento, el abordaje por via laparoscópica es excelente opción con excelentes resultados, con menor riesgo de complicaciones, y menor sangrado que cirugía abierta.


Nephron-sparing surgery (partial nephrectomy) has provided multiple benefits, mainly in patients with small kidney lesions or concomitant diseases that affect overall kidney function in long term, also in patients with a single functional kidney, either congenital or by surgery, end-stage renal disease, bilateral renal tumors or with chromosomal diseases that affects the renal function. The case of a 52-years-old male patient is presented with a 10-cm right kidney tumor in the interpolar region, with not functional left kidney exclusion due to an obstructive process by congenital ureteropyelic stenosis. Right nephron-sparing nephrectomy was performed despite the location and size of the tumor, obtaining excellent oncological and functional results. Follow-up at twelve months of postoperative evolution showed no data of tumor activity, presenting renal function with creatinine of 1.6 mg/dl, with satisfactory evolution. Conclusions: Partial nephrectomy is the standard management for small-volume renal tumors located in the renal cortex and polar areas, or not functional contralateral kidney; but there is the dilemma, when patients appear with impaired renal function or tumors located near the renal hilum by > 5 cm of diameter, the risk of performs this procedure must be taken, the laparoscopic approach is an excellent option. with great results, and minor bleeding than open surgery.

6.
Cancer Treat Res Commun ; 31: 100566, 2022.
Article in English | MEDLINE | ID: mdl-35487053

ABSTRACT

PURPOSE: It is imperative to spare functioning kidneys from high radiation doses when they are near enough to radiotherapy (RT) target volumes in patients with polycystic kidney disease (PKD). To achieve this intent, we designed the unique approach that we report here. METHODS AND MATERIALS: The patient who has PKD, presented with B-cell lymphoma involving paraaortic lymph nodes. After completing chemotherapy, RT was planned to the residual nodal disease. The diagnostic positron emission tomography computed tomography (PETCT) scan was fused with the RT planning CT scan. 18F-2-deoxy-2(F)-fluro-d-glucose (FDG) avid active kidneys were contoured separately, and the treatment plan was optimized to avoid these volumes. RESULTS: The functional volume was 17.52% of the right kidney whereas it was 7.44% of the left. The mean doses were 4.61 Gy and 4.2 Gy, respectively. The baseline estimated glomerular filtration rate (eGFR) was >60 mL/min; at 18 months follow-up, it was 62 mL/min. CONCLUSIONS: Delineation of functional nephrons was feasible while utilizing the staging FDG-PETCT scan for radiotherapy contouring in our patient, which aided to achieve the optimal dose-volume constraints. Further studies are warranted to analyze and quantify the benefit of this easily accessible method in the future.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Lymphoma , Polycystic Kidney Diseases , Carcinoma, Non-Small-Cell Lung/pathology , Female , Fluorodeoxyglucose F18 , Humans , Lung Neoplasms/pathology , Male , Nephrons/pathology , Polycystic Kidney Diseases/radiotherapy , Radiopharmaceuticals/therapeutic use
7.
J Am Soc Nephrol ; 33(7): 1308-1322, 2022 07.
Article in English | MEDLINE | ID: mdl-35383123

ABSTRACT

BACKGROUND: We reasoned that unraveling the dynamic changes in accessibility of genomic regulatory elements and gene expression at single-cell resolution will inform the basic mechanisms of nephrogenesis. METHODS: We performed single-cell ATAC-seq and RNA-seq both individually (singleomes; Six2GFP cells) and jointly in the same cells (multiomes; kidneys) to generate integrated chromatin and transcriptional maps in mouse embryonic and neonatal nephron progenitor cells. RESULTS: We demonstrate that singleomes and multiomes are comparable in assigning most cell states, identification of new cell type markers, and defining the transcription factors driving cell identity. However, multiomes are more precise in defining the progenitor population. Multiomes identified a "pioneer" bHLH/Fox motif signature in nephron progenitor cells. Moreover, we identified a subset of Fox factors exhibiting high chromatin activity in podocytes. One of these Fox factors, Foxp1, is important for nephrogenesis. Key nephrogenic factors are distinguished by strong correlation between linked gene regulatory elements and gene expression. CONCLUSION: Mapping the regulatory landscape at single-cell resolution informs the regulatory hierarchy of nephrogenesis. Paired single-cell epigenomes and transcriptomes of nephron progenitors should provide a foundation to understand prenatal programming, regeneration after injury, and ex vivo nephrogenesis.


Subject(s)
Chromatin , Podocytes , Animals , Cell Differentiation/genetics , Chromatin/metabolism , Female , Homeodomain Proteins/genetics , Kidney/metabolism , Mice , Nephrons/metabolism , Organogenesis/genetics , Podocytes/metabolism , Pregnancy , Transcription Factors/genetics , Transcription Factors/metabolism
8.
G Ital Nefrol ; 39(6)2022 Dec 21.
Article in Italian | MEDLINE | ID: mdl-36655835

ABSTRACT

The interest in determining the number of nephrons in the kidney dates back to the 1960s, when an influential laboratory method for determining ex vivo the number of nephrons in the kidneys was described by Bricker. Over the years, various methods have been developed to estimate the number of nephrons in living beings as accurately as possible. These modern methods combine data such as the glomerular density, the percentage of glomeruli in sclerosis calculated from biopsy samples, and the kidney volume, which can be precisely estimated from magnetic resonance, CT scan, or specific ultrasound methods. As the reduction in the number of functioning nephrons is closely connected with an increased risk of progression of renal disease (especially in patients with nephrotic syndrome) and hypertension, its introduction into clinical practice could allow a precise stratification of progression risk in patients with kidney disease and a better understanding of the mechanisms that contribute to the loss of functioning nephrons.


Subject(s)
Kidney Diseases , Nephrologists , Humans , Nephrons , Kidney/diagnostic imaging , Kidney/pathology , Kidney Glomerulus/pathology , Kidney Diseases/diagnostic imaging , Kidney Diseases/pathology , Biopsy
9.
Chinese Journal of Nephrology ; (12): 536-542, 2022.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-958057

ABSTRACT

Objective:To explore the isolation and culture methods of mouse parietal epithelial cells (PECs) of Bowman′s capsule, so as to provide a cell tool for further study.Methods:Mouse renal corpuscles were isolated by cell sieving combined with magnetic separation. After primary culture, identified parietal epithelial cells were induced to differentiate into podocytes. Immunofluorescence staining, real-time quantitative PCR and Western blotting were used to detect specific markers of parietal epithelial cells and podocytes.Results:Primary cultured PECs grew like paving stone and expressed Claudin-1 (PECs specific marker), CD133 (stem cell marker) and CD24 (stem cell marker), without the expression of tubular epithelial cell proteins, mesangial cell and podocyte specific proteins. Cultured to 6 generations in vitro, the PECs still expressed Claudin-1, CD133 and CD24. After incubated with differentiation medium, PECs were able to express podocyte markers WT-1 and Synaptopodin. Conclusion:The renal corpuscles are extracted by cell sieving combined with magnetic separation, and the mouse PECs successfully cultured in vitro can be induced to express podocytes′ markers.

10.
Arch Argent Pediatr ; 119(5): e480-e486, 2021 10.
Article in English, Spanish | MEDLINE | ID: mdl-34569748

ABSTRACT

A low birth weight (LBW, < 2500 g), intrauterine growth restriction (IUGR), and preterm birth (PB, < 37 weeks of gestational age) are the most common clinical factors for an altered programming of nephron number and are associated with a greater risk for hypertension, proteinuria, and kidney disease later in life. At present, an indirect assessment of total nephron number based on postnatal markers is the most important approach to evaluate the risk for future kidney disorders in newborn infants with a LBW, IUGR or PB. Here we describe advances made in animal experiments and biochemical markers in humans, and the recommendations for the prevention of preconception kidney injury, including social factors and chronic diseases. According to the evidence, IUGR and prematurity alone can modulate nephrogenesis and kidney function, and, if occurring simultaneously, their effects tend to be cumulative.


El bajo peso al nacer (BP, < 2500 g), la restricción del crecimiento intrauterino (RCIU) y el parto prematuro (PP, < 37 semanas de gestación) son los factores clínicos más habituales para la programación alterada del número de nefronas y se asocian con un mayor riesgo de hipertensión, proteinuria y enfermedad renal futura en la vida. En la actualidad la evaluación indirecta del número total de nefronas mediante el uso de marcadores en el período posnatal representa el enfoque principal para evaluar el riesgo de evolución futura de los trastornos renales en los recién nacidos con BP, RCIU o PP. Se presentan los avances en la investigación en animales y sobre marcadores bioquímicos en humanos, y recomendaciones para la prevención del daño renal preconcepcional, incluidos los factores sociales y las enfermedades crónicas. La evidencia demuestra que la restricción de crecimiento y la prematuridad solas son capaces de modular la nefrogénesis y la función renal y, cuando son concurrentes, sus efectos tienden a ser acumulativos.


Subject(s)
Kidney Diseases , Premature Birth , Adult , Animals , Female , Gestational Age , Humans , Infant, Low Birth Weight , Infant, Newborn , Kidney , Kidney Diseases/epidemiology , Kidney Diseases/etiology , Nephrons , Pregnancy
11.
Arch. argent. pediatr ; 119(5): e480-e486, oct. 2021. ilus
Article in English, Spanish | LILACS, BINACIS | ID: biblio-1292126

ABSTRACT

El bajo peso al nacer (BP, < 2500 g), la restricción del crecimiento intrauterino (RCIU) y el parto prematuro (PP, < 37 semanas de gestación) son los factores clínicos más habituales para la programación alterada del número de nefronas y se asocian con un mayor riesgo de hipertensión, proteinuria y enfermedad renal futura en la vida. En la actualidad la evaluación indirecta del número total de nefronas mediante el uso de marcadores en el período posnatal representa el enfoque principal para evaluar el riesgo de evolución futura de los trastornos renales en los recién nacidos con BP, RCIU o PP.Se presentan los avances en la investigación en animales y sobre marcadores bioquímicos en humanos, y recomendaciones para la prevención del daño renal preconcepcional, incluidos los factores sociales y las enfermedades crónicas. La evidencia demuestra que la restricción de crecimiento y la prematuridad solas son capaces de modular la nefrogénesis y la función renal y, cuando son concurrentes, sus efectos tienden a ser acumulativos.


A low birth weight (LBW, < 2500 g), intrauterine growth restriction (IUGR), and preterm birth (PB, < 37 weeks of gestational age) are the most common clinical factors for an altered programming of nephron number and are associated with a greater risk for hypertension, proteinuria, and kidney disease later in life. At present, an indirect assessment of total nephron number based on postnatal markers is the most important approach to evaluate the risk for future kidney disorders in newborn infants with a LBW, IUGR or PB.Here we describe advances made in animal experiments and biochemical markers in humans, and the recommendations for the prevention of preconception kidney injury, including social factors and chronic diseases. According to the evidence, IUGR and prematurity alone can modulate nephrogenesis and kidney function, and, if occurring simultaneously, their effects tend to be cumulative.


Subject(s)
Humans , Animals , Female , Pregnancy , Infant, Newborn , Adult , Premature Birth , Kidney Diseases/etiology , Kidney Diseases/epidemiology , Infant, Low Birth Weight , Gestational Age , Kidney , Nephrons
12.
J Stroke Cerebrovasc Dis ; 30(5): 105720, 2021 May.
Article in English | MEDLINE | ID: mdl-33706193

ABSTRACT

BACKGROUND: Chronic kidney disease (CKD) is associated with poor outcomes among stroke survivors. In Africa, where both stroke and CKD incidence rates are escalating, little, if anything, is known about the burden of CKD among stroke survivors. OBJECTIVE: To assess the frequency and factors associated with CKD among stroke survivors by primary stroke types. METHODS: Stroke registry data were prospectively collected on consecutively encountered stroke survivors seen at an out-patient clinic in Ghana between January 2018 and March 2020. We calculated estimated glomerular filtration rate (eGFR) using the CKD-EPI formula and defined CKD as eGFR <60ml/min. Factors associated with CKD were assessed using multiple logistic regression modelling. RESULTS: Among 759 stroke survivors, 159 had CKD giving a prevalence of 21.0% (95%CI: 18.1% - 23.8%). The mean age of those with CKD was 61.6 ± 14.2 years compared with 57.5 ± 13.6 years, p=0.0007 among those without CKD. Five factors remained significantly associated with CKD with the following adjusted odds ratio (aOR and 95% CI). Age per decile rise 1.30 (1.13-1.50), male sex 1.99 (1.36-2.93), rural dwelling residence 1.95 (1.06-3.59), prior use of antihypertensive meds before index stroke onset 1.63 (1.08-2.47), and number of antihypertensive medication classes 1.25 (1.06-1.45). CONCLUSION: 1 in 5 stroke survivors have evidence of chronic kidney disease in this Ghanaian study. Targeted interventions focusing on optimizing blood pressure control and rural dwellers may mitigate their risk for adverse outcomes.


Subject(s)
Renal Insufficiency, Chronic/epidemiology , Stroke/epidemiology , Adult , Aged , Aged, 80 and over , Blood Pressure , Comorbidity , Cross-Sectional Studies , Female , Ghana/epidemiology , Glomerular Filtration Rate , Humans , Hypertension/diagnosis , Hypertension/epidemiology , Hypertension/physiopathology , Kidney/physiopathology , Life Style , Male , Middle Aged , Prevalence , Prognosis , Prospective Studies , Registries , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/mortality , Renal Insufficiency, Chronic/physiopathology , Residence Characteristics , Risk Assessment , Risk Factors , Stroke/diagnosis , Stroke/mortality , Time Factors
13.
Hypertension ; 77(3): 759-767, 2021 03 03.
Article in English | MEDLINE | ID: mdl-33486988

ABSTRACT

The development of high blood pressure is influenced by genetic and environmental factors, with high salt intake being a known environmental contributor. Humans display a spectrum of sodium-sensitivity, with some individuals displaying a significant blood pressure rise in response to increased sodium intake while others experience almost no change. These differences are, in part, attributable to genetic variation in pathways involved in sodium handling and excretion. ENaC (epithelial sodium channel) is one of the key transporters responsible for the reabsorption of sodium in the distal nephron. This channel has an important role in the regulation of extracellular fluid volume and consequently blood pressure. Herein, we review the role of ENaC in the development of salt-sensitive hypertension, and present mechanistic insights into the regulation of ENaC activity and how it may accelerate sodium-induced damage and dysfunction. We discuss the traditional role of ENaC in renal sodium reabsorption and review work addressing ENaC expression and function in the brain, vasculature, and immune cells, and how this has expanded the implications for its role in the initiation and progression of salt-sensitive hypertension.


Subject(s)
Blood Pressure/physiology , Epithelial Sodium Channels/metabolism , Hypertension/physiopathology , Sodium Chloride, Dietary/metabolism , Animals , Humans , Hypertension/etiology , Hypertension/metabolism , Ion Transport , Kidney/metabolism , Models, Biological , Nephrons/metabolism , Sodium Chloride, Dietary/administration & dosage , Sodium Chloride, Dietary/adverse effects
14.
Methods Mol Biol ; 2258: 171-192, 2021.
Article in English | MEDLINE | ID: mdl-33340361

ABSTRACT

Our understanding in the inherent properties of human pluripotent stem cells (hPSCs) have made possible the development of differentiation procedures to generate three-dimensional tissue-like cultures, so-called organoids. Here we detail a stepwise methodology to generate kidney organoids from hPSCs. This is achieved through direct differentiation of hPSCs in two-dimensional monolayer culture toward the posterior primitive streak fate, followed by induction of intermediate mesoderm-committed cells, which are further aggregated and cultured in three-dimensions to generate kidney organoids containing segmented nephron-like structures in a process that lasts 20 days. We also provide a concise description on how to assess renal commitment during the time course of kidney organoid generation. This includes the use of flow cytometry and immunocytochemistry analyses for the detection of specific renal differentiation markers.


Subject(s)
Cell Differentiation , Kidney/physiology , Pluripotent Stem Cells/physiology , Tissue Engineering , Cell Culture Techniques , Cells, Cultured , Flow Cytometry , Fluorescent Antibody Technique , Gene Expression Regulation, Developmental , Humans , Kidney/cytology , Microscopy, Fluorescence , Morphogenesis , Organoids , Signal Transduction , Time Factors
15.
J Urol ; 205(4): 1039-1046, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33216692

ABSTRACT

PURPOSE: We reviewed the oncologic and surgical outcomes of endoscopic treatments for low grade upper tract urothelial carcinoma, and assessed the prognostic significance of tumor size, location and multifocality. MATERIALS AND METHODS: We retrospectively reviewed all patients who underwent endoscopic treatment for low grade upper tract urothelial carcinoma at our institution between 2014 and 2019. Tumors were treated with a dual laser generator, which alternately produces holmium and neodymium lasers. A stringent ureteroscopic followup protocol was conducted. We looked for an association between outcome and tumor size, location or multifocality, and for predictive factors for time to local recurrence and progression. RESULTS: The cohort included 59 patients (62 renal units), 27% of tumors were multifocal and 40% were >2 cm. The median followup time was 22 months (IQR 11-41), and the median number of ureteroscopies was 5.5 (4-9). Local recurrence was observed in 46 renal units (74.1%) at a median of 6.5 months after initial surgery. Four patients (6.4%) developed disease progression and were referred for radical surgery: 2 had pathological progression and 2 had a rapid and high volume local recurrence, and 1 later developed metastatic disease. The progression-free rate was 93.2%. Tumor location in kidney (p=0.03, HR 1.95) and multifocality (p=0.005, HR 3.25) significantly predicted time to local recurrence. No factor predicted time to progression. CONCLUSIONS: Ureteroscopic treatment of large, multifocal, low grade upper tract urothelial carcinoma is feasible, does not involve significant complications and has good short-term oncologic outcomes, with a 93.2% progression-free survival rate. Tumors located in the kidney and multifocality yielded shorter time to local recurrence but not progression.


Subject(s)
Carcinoma, Transitional Cell/surgery , Kidney Neoplasms/surgery , Laser Therapy/methods , Nephrectomy/methods , Ureteroscopy/methods , Urinary Bladder Neoplasms/surgery , Aged , Disease Progression , Female , Glomerular Filtration Rate , Humans , Male , Prognosis , Retrospective Studies
16.
Cell Death Discov ; 6: 32, 2020.
Article in English | MEDLINE | ID: mdl-32377395

ABSTRACT

The transcription factor EB (TFEB) regulates the expression of target genes bearing the Coordinated Lysosomal Expression and Regulation (CLEAR) motif, thereby modulating autophagy and lysosomal biogenesis. Furthermore, TFEB can bind to the promoter of autophagy-associated genes and induce the formation of autophagosomes, autophagosome-lysosome fusion, and lysosomal cargo degradation. An increasing number of studies have shown that TFEB stimulates the intracellular clearance of pathogenic factors by enhancing autophagy and lysosomal function in multiple kidney diseases, such as cystinosis, acute kidney injury, and diabetic nephropathy. Taken together, this highlights the importance of developing novel therapeutic strategies against kidney diseases based on TFEB regulation. In this review, we present an overview of the current data on TFEB and its implication in kidney disease.

17.
Hypertension ; 75(6): 1447-1454, 2020 06.
Article in English | MEDLINE | ID: mdl-32336231

ABSTRACT

The (P)RR ([pro]renin receptor) was identified as a new component of the renin-angiotensin system. We previously reported that high salt (HS) intake increased the (P)RR expression in several nephron segments of Sprague-Dawley rats. Other studies reported HS intake increased the XO (xanthine oxidase) activity and an MR (mineralocorticoid receptor) antagonist inhibited HS intake-increased (P)RR expression in the kidneys of Dahl salt-sensitive (DS) rats. The present study examined the effects of HS intake on (P)RR expression in the kidney of DS rats. Male DS rats were fed a normal salt diet or an HS diet for 4 weeks. Some of the rats fed on the HS diet were treated with the XO inhibitor, febuxostat, and the MR antagonist, spironolactone. Immunoblot and immunohistochemical analyses showed that HS intake increased (P)RR expression in the renal cortex by 22.6-fold, the proximal tubules by 4.9-fold and the distal tubules, respectively. Both febuxostat and spironolactone inhibited HS intake-increased (P)RR expression in the renal cortex. Febuxostat inhibited HS intake-increased (P)RR expression in the proximal tubules, whereas spironolactone inhibited HS intake-increased (P)RR expression in the distal tubules. Additionally, deoxycorticosterone acetate increased (P)RR expression in the renal cortex and distal tubules but not in the proximal tubules of DS rats fed the normal salt diet. These results indicate that HS intake greatly increases (P)RR expression in the renal cortex of DS rats. The mechanisms of HS intake-increased (P)RR expression may work in an XO-dependent manner in the proximal tubules and an MR-dependent manner in the distal tubules.


Subject(s)
Febuxostat/pharmacology , Hypertension/metabolism , Nephrons , Receptors, Cell Surface/metabolism , Sodium Chloride, Dietary/pharmacology , Spironolactone/pharmacology , Xanthine Oxidase , Animals , Blood Pressure/drug effects , Blood Pressure/physiology , Flavoring Agents/pharmacology , Gene Expression Regulation/drug effects , Mineralocorticoid Receptor Antagonists/pharmacology , Nephrons/drug effects , Nephrons/metabolism , Rats , Rats, Inbred Dahl , Renin-Angiotensin System/drug effects , Renin-Angiotensin System/physiology , Xanthine Oxidase/antagonists & inhibitors , Xanthine Oxidase/metabolism , Prorenin Receptor
18.
Clin J Am Soc Nephrol ; 15(5): 723-731, 2020 05 07.
Article in English | MEDLINE | ID: mdl-32188635

ABSTRACT

Congenital anomalies of the kidneys and urinary tracts (CAKUT) are disorders caused by defects in the development of the kidneys and their outflow tracts. The formation of the kidneys begins at week 3 and nephrogenesis continues until week 36, therefore, the kidneys and outflow tracts are susceptible to environmental risk factors that perturb development throughout gestation. Many genes have been implicated in kidney and outflow tract development, and mutations have been identified in patients with CAKUT. In severe cases of CAKUT, when the kidneys do not form, the fetus will not survive. However, in less severe cases, the baby can survive with combined kidney and outflow tract defects or they may only be identified in adulthood. In this review, we will cover the clinical presentation of CAKUT, its epidemiology, and its long-term outcomes. We will then discuss risk factors for CAKUT, including genetic and environmental contributions. Although severe CAKUT is rare, low nephron number is a much more common disorder with its effect on kidney function increasingly apparent as a person ages. Low nephron number appears to arise by the same mechanisms as CAKUT, but it differs in terms of the magnitude of the insult and the timing of when it occurs during gestation. By understanding the causes of CAKUT and low nephron number, we can begin to identify preventive treatments and establish clinical guidelines for how these patients should be followed.


Subject(s)
Kidney/abnormalities , Urogenital Abnormalities , Vesico-Ureteral Reflux , Animals , Disease Models, Animal , Fetal Death , Genetic Predisposition to Disease , Humans , Kidney/physiopathology , Phenotype , Prognosis , Risk Assessment , Risk Factors , Severity of Illness Index , Urogenital Abnormalities/diagnosis , Urogenital Abnormalities/genetics , Urogenital Abnormalities/physiopathology , Urogenital Abnormalities/therapy , Vesico-Ureteral Reflux/diagnosis , Vesico-Ureteral Reflux/genetics , Vesico-Ureteral Reflux/physiopathology , Vesico-Ureteral Reflux/therapy
19.
Vet Clin North Am Exot Anim Pract ; 23(1): 1-19, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31759441

ABSTRACT

The avian kidney contains both cortical or reptilian and medullary or mammalian nephrons. The kidney filters up to 11 times the total body water daily. Approximately 95% of this volume is reabsorbed by tubular reabsorption, which likely results from a change in the rate of filtration and/or the rate of reabsorption. These changes can result because of the antidiuretic hormone arginine vasotocin. The urinary concentrating ability generally varies inversely with body mass; however, birds can concentrate their urine, often at 2 to 3 times the osmolality of plasma. Further concentration of urine may occur by retroperistalsis.


Subject(s)
Birds/physiology , Osmoregulation , Vasoconstrictor Agents/metabolism , Vasotocin/metabolism , Animals , Birds/anatomy & histology , Kidney/anatomy & histology , Kidney/physiology , Osmolar Concentration , Urine
20.
Cell Mol Life Sci ; 77(12): 2257-2273, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31807815

ABSTRACT

Kidney organoids can be generated from human pluripotent stem cells (PSCs) using protocols that resemble the embryonic development of the kidney. The renal structures thus generated offer great potential for disease modeling, drug screening, and possibly future therapeutic application. At the same time, use of these PSC-derived organoids is hampered by lack of maturation and off-target differentiation. Here, we review the main protocols for the generation of kidney organoids from human-induced PSCs, discussing their advantages and limitations. In particular, we will focus on the vascularization of the kidney organoids, which appears to be one of the critical factors to achieve maturation and functionality of the organoids.


Subject(s)
Kidney/cytology , Organoids/cytology , Pluripotent Stem Cells/cytology , Animals , Cell Culture Techniques/methods , Cell Differentiation/physiology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...